[Multiple myeloma and intravenous immunoglobulins]

Rev Med Interne. 2007 Jun:28 Spec No 2:5-6. doi: 10.1016/s0248-8663(07)80008-7.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Agammaglobulinemia / complications
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Female
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infections / complications
  • Male
  • Multicenter Studies as Topic
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Multiple Myeloma / mortality
  • Prospective Studies
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / therapeutic use
  • Pyrazines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Retrospective Studies
  • Time Factors

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Immunoglobulins, Intravenous
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib